4.7 Article

Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 109, Issue 12, Pages 2210-2229

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2022.11.006

Keywords

-

Funding

  1. Intramural Research Program (IRP) of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health
  2. Cancer Research UK [C8216/A6129, C588/A19167]
  3. National Institutes of Health (NIH) [R01 CA83115]
  4. EU

Ask authors/readers for more resources

In this study, massively parallel reporter assays (MPRAs) and variant scoring were used to systematically prioritize functional variants and susceptibility genes from cutaneous melanoma GWAS loci. Integration of multi-layer annotation and overlaying with expression or methylation quantitative trait loci (eQTLs or meQTLs) identified candidate susceptibility genes for majority of the variants. This study also highlighted the role of cellular contexts in the functionality of susceptibility variants.
The most recent genome-wide association study (GWAS) of cutaneous melanoma identified 54 risk-associated loci, but functional var-iants and their target genes for most have not been established. Here, we performed massively parallel reporter assays (MPRAs) by using malignant melanoma and normal melanocyte cells and further integrated multi-layer annotation to systematically prioritize functional variants and susceptibility genes from these GWAS loci. Of 1,992 risk-associated variants tested in MPRAs, we identified 285 from 42 loci (78% of the known loci) displaying significant allelic transcriptional activities in either cell type (FDR < 1%). We further characterized MPRA-significant variants by motif prediction, epigenomic annotation, and statistical/functional fine-mapping to create integrative variant scores, which prioritized one to six plausible candidate variants per locus for the 42 loci and nominated a single variant for 43% of these loci. Overlaying the MPRA-significant variants with genome-wide significant expression or methylation quantitative trait loci (eQTLs or meQTLs, respectively) from melanocytes or melanomas identified candidate susceptibility genes for 60% of variants (172 of 285 variants). CRISPRi of top-scoring variants validated their cis-regulatory effect on the eQTL target genes, MAFF (22q13.1) and GPRC5A (12p13.1). Finally, we identified 36 melanoma-specific and 45 melanocyte-specific MPRA-significant variants, a subset of which are linked to cell-type-specific target genes. Analyses of transcription factor availability in MPRA datasets and variant-transcription-factor interaction in eQTL datasets highlighted the roles of transcription factors in cell-type-specific variant functionality. In conclusion, MPRAs along with variant scoring effectively prioritized plausible candidates for most melanoma GWAS loci and highlighted cellular contexts where the susceptibility variants are functional.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available